Showing results (211-220 of 322) with videos related to

Sort By:
Pageof 33
Neuroimage|September 15, 2023
Attentional effects on local V1 microcircuits explain selective V1-V4 communicationChristini Katsanevaki, André M Bastos, Hayriye Cagnan, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptidesH W Nijman, J G Houbiers, S H van der Burg, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
Nuclear Medicine Communications|December 1, 1992
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancerJ G Tibben, L F Massuger, R A Claessens, et al.
European Journal of Clinical Investigation|August 23, 2002
Effects of hormone replacement therapy on blood plateletsA Thijs, W M van Baal, M J van der Mooren, et al.
Thrombosis and Haemostasis|October 4, 2002
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trialM S Post, M J van der Mooren, C D A Stehouwer, et al.
Climacteric : the Journal of the International Menopause Society|September 28, 2011
Less mammographic density after nasal versus oral administration of postmenopausal hormone therapyJ A A M van Dijck, J D M Otten, N Karssemeijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2000
Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancerI van Zanten-Przybysz, C F Molthoff, J C Roos, et al.
BMC Psychiatry|February 18, 2011
P300 amplitude is insensitive to working memory load in schizophreniaPablo A Gaspar, Sergio Ruiz, Francisco Zamorano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled studyG W de Valk-de Roo, C D Stehouwer, P Meijer, et al.
Pageof 33